Particle size analysis in pharmaceutics: Principles, methods and applications

被引:360
作者
Shekunov, Boris Y. [1 ]
Chattopadhyay, Pratibhash
Tong, Henry H. Y.
Chow, Albert H. L.
机构
[1] Pharmaceut Technol, Ferro Pfanstiehl Labs, Independence, OH 44131 USA
[2] Macao Polytech Inst, Sch Hlth Sci, Macau, SAR, Peoples R China
[3] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China
关键词
aerodynamic diameter; aerosols; agglomeration; dispersion; micro and nanosuspensions; impactor; inhaler; PAT; particle size distribution; powders; respiratory drug delivery; shape; tablets;
D O I
10.1007/s11095-006-9146-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Physicochemical and biopharmaceutical properties of drug substances and dosage forms can be highly affected by the particle size, a critical process parameter in pharmaceutical production. The fundamental issue with particle size analysis is the variety of equivalent particle diameters generated by different methods, which is largely ascribable to the particle shape and particle dispersion mechanism involved. Thus, to enable selection of the most appropriate or optimal sizing technique, cross-correlation between different techniques may be required. This review offers an in-depth discussion on particle size analysis pertaining to specific pharmaceutical applications and regulatory aspects, fundamental principles and terminology, instrumentation types, data presentation and interpretation, in-line and process analytical technology. For illustration purposes, special consideration is given to the analysis of aerosols using time-of-flight and cascade impactor measurements, which is supported by a computational analysis conducted for this review. Physicochemical and biopharmaceutical properties of drug substances and dosage forms can be highly affected by the particle size, a critical process parameter in pharmaceutical production. The fundamental issue with particle size analysis is the variety of equivalent particle diameters generated by different methods, which is largely ascribable to the particle shape and particle dispersion mechanism involved. Thus, to enable selection of the most appropriate or optimal sizing technique, cross-correlation between different techniques may be required. This review offers an in-depth discussion on particle size analysis pertaining to specific pharmaceutical applications and regulatory aspects, fundamental principles and terminology, instrumentation types, data presentation and interpretation, in-line and process analytical technology. For illustration purposes, special consideration is given to the analysis of aerosols using time-of-flight and cascade impactor measurements, which is supported by a computational analysis conducted for this review.
引用
收藏
页码:203 / 227
页数:25
相关论文
共 123 条
[1]  
ALLEN T, 1997, POWDER SAMPLING PART, V15
[2]   Skin penetration and distribution of polymeric nanoparticles [J].
Alvarez-Román, R ;
Naik, A ;
Kalia, Y ;
Guy, RH ;
Fessi, H .
JOURNAL OF CONTROLLED RELEASE, 2004, 99 (01) :53-62
[3]  
Baldyga J., 2004, SUPERCRITICAL FLUID, P91
[4]   CALIBRATION AND USE OF THE AERODYNAMIC PARTICLE SIZER (APS 3300) [J].
BARON, PA .
AEROSOL SCIENCE AND TECHNOLOGY, 1986, 5 (01) :55-67
[5]   Micrometer-scale particle sizing by laser diffraction: Critical impact of the imaginary component of refractive index [J].
Beekman, A ;
Shan, DX ;
Ali, A ;
Dai, WG ;
Ward-Smith, S ;
Goldenberg, M .
PHARMACEUTICAL RESEARCH, 2005, 22 (04) :518-522
[6]   Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles [J].
Bennett, FS ;
Carter, PA ;
Rowley, G ;
Dandiker, Y .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (01) :99-103
[7]  
BOER AH, 2000, P C RESP DRUG DEL PA, P585
[8]   Comparison of particle sizing techniques in the case of inhalation dry powders [J].
Bosquillon, C ;
Lombry, C ;
Preat, V ;
Vanbever, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (12) :2032-2041
[9]  
BRESSMAN JB, 2000, EUR J PHARM SCI S2, V11, pS73
[10]   PHYSICAL CHARACTERIZATION OF PHARMACEUTICAL SOLIDS [J].
BRITTAIN, HG ;
BOGDANOWICH, SJ ;
BUGAY, DE ;
DEVINCENTIS, J ;
LEWEN, G ;
NEWMAN, AW .
PHARMACEUTICAL RESEARCH, 1991, 8 (08) :963-973